The Journal of Medical Sciences

Register      Login

VOLUME 10 , ISSUE 1--4 ( January-December, 2024 ) > List of Articles


Morphological and Immunohistochemical Spectrum of Synovial Sarcoma: Inferences Deduced from the Study of the Case Series

Priyadarshini K Rajeswaran, Vidhyalakshmi Sreenivasan, Shanthakumari Sivanandham

Keywords : Differential diagnosis, Immunohistochemistry markers study, Morphological mimics, Synovial sarcoma

DOI: 10.5005/jp-journals-10045-00262

License: CC BY-NC 4.0

Published Online: 10-06-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Objective: Synovial sarcoma (SS) is a rare mesenchymal neoplasm that can occur in various sites with a morphological spectrum, and it has the ability to mimic other malignant neoplasms. Materials and methods: For this study, 15 cases of SS reported over a period of 5 years were analyzed. Results: The most common site of occurrence was the thorax. Monophasic histology was common in 60% of the cases taken for this study. The differential diagnosis varied depending upon the site and histology. The common aspects shared by all the cases of SS were variable immunohistochemistry (IHC) marker expression of epithelial membrane antigen (EMA), cytokeratin, S100, cluster of differentiation 99 (CD99), B-cell leukemia/lymphoma 2 protein (Bcl-2), and transducin-like enhancer of split-1 (TLE1), and being consistently negative for CD34. Conclusion: This study highlights the importance of knowledge as well as awareness about various histomorphological spectrums of SS in different sites.

PDF Share
  1. Kransdorf M. Malignant soft-tissue tumors in a large referral population: distribution of diagnoses by age, sex, and location. Am J Roentgenol 1995;164(1):129–134. DOI: 10.2214/ajr.164.1.7998525
  2. Enzinger FM. Malignant soft tissue tumors of uncertain type. Soft Tissue Tumors. 1995.
  3. de Alava E, Lessnick SL, Stamenkovic I. WHO Classification of Tumours, Soft Tissue and Bone Tumors, 5th edition. Lyon Cedex, France: International Agency for Research on Cancer (IARC); 2020. pp. 323–325.
  4. Thway K, Fisher C. Synovial sarcoma: defining features and diagnostic evolution. Ann Diagn Pathol 2014;18(6):369–380. DOI: 10.1016/j.anndiagpath.2014.09.002
  5. Jayasooriya PR, Madawalagamage LN, Mendis BR, et al. Diagnostic approach to synovial sarcoma of the head and neck illustrated by two cases arising in the face and oral cavity. Dermatopathology 2016;3(1):13–22. DOI: 10.1159/000444876
  6. Requena DO, Longacre TA, Rosenberg AE, et al. Synovial sarcoma of the gastrointestinal tract. Modern Pathol 2024;37(1):100383. DOI: 10.1016/j.modpat.2023.100383
  7. Romeo S, Rossi S, Acosta Marín M, et al. Primary synovial sarcoma (SS) of the digestive system: a molecular and clinicopathological study of fifteen cases. Clin Sarcoma Res 2015;5(1):1–8. DOI: 10.1186/s13569-015-0021-3
  8. He X, Xiong B, Zhou T, et al. Diagnostic value of TLE1 for synovial sarcoma: immunohistochemical analyses of genetically confirmed synovial sarcomas and nonsynovial sarcomas. Int J Clin Exp Pathol 2016;9(4):4339–4350.
  9. Foo WC, Cruise MW, Wick MR, et al. Immunohistochemical staining for TLE1 distinguishes synovial sarcoma from histologic mimics. Am J Clin Pathol 2011;135(6):839–844. DOI: 10.1309/AJCP45SSNAOPXYXU
  10. Rekhi B, Basak R, Desai SB, et al. Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas. Indian J Med Res 2012;136(5):766–775.
  11. Gazendam AM, Popovic S, Munir S, et al. Synovial sarcoma: a clinical review. Curr Oncol 2021;28(3):1909–1920. DOI: 10.3390/curroncol28030177
  12. Abdelkrim SB, Trabelsi A, Hammedi F, et al. Synovial sarcoma: a clinicopathological and radiological study of 12 cases seen over 18 years. World J Oncol 2010;1(1):14–18. DOI: 10.4021/wjon2009.12.1201
  13. Hellwinkel JE, Farmer RP, Heare A, et al. Primary intra-articular synovial sarcoma of the knee: a report of two cases and review of the literature. Int J Radiol Imag Technol 2018;4(1):1–8. DOI: 10.23937/2572-3235.1510031
  14. Karaca M, Başarır K, Savran MD, et al. Intriguing tumor, synovial sarcoma: hard to diagnose, harder to treat. Research Square 2023;1–21. DOI: 10.21203/
  15. Blay JY, von Mehren M, Jones RL, et al. Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies. ESMO Open 2023;8(5):101618. DOI: 10.1016/j.esmoop.2023.101618
  16. Venkatramani R, Xue W, Randall RL, et al. Synovial sarcoma in children, adolescents, and young adults: a report from the Children's oncology group ARST0332 study. J Clin Oncol 2021;39(35):3927–3937. DOI: 10.1200/JCO.21.01628
  17. Cho EB, Lee SK, Kim JY, et al. Synovial sarcoma in the extremity: diversity of imaging features for diagnosis and prognosis. Cancers 2023;15(19):4860. DOI: 10.3390/cancers15194860
  18. Gonçalves S, Soares C, Ribeiro R, et al. Unveiling the mystery: a case report on oropharyngeal synovial sarcoma. Cureus 2023;15(9):e44703. DOI: 10.7759/cureus.44703
  19. Murphey MD, Gibson MS, Jennings BT, et al. Imaging of synovial sarcoma with radiologic-pathologic correlation. Radiographics 2006;26(5):1543–1565. DOI: 10.1148/rg.265065084
  20. Bellur S, Balasundaram S. Primary malignant synovial tumor in the mediastinum. Cureus 2021;13(12):e20076. DOI: 10.7759/cureus.20076
  21. Shah S, Sankrithi P, Shah K, et al. Primary pulmonary synovial sarcoma in a 49-year-old male. Cureus 2020;12(12):e11899. DOI: 10.7759/cureus.11899
  22. Baranov E, McBride MJ, Bellizzi AM, et al. A novel SS18-SSX fusion-specific antibody for the diagnosis of synovial sarcoma. Am J Surg Pathol 2020;44(7):922–933. DOI: 10.1097/PAS.0000000000001447
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.